Public Notice on Environmental Information of Jiaozuo Jiankangyuan Bioproducts Co., Ltd. in 2023
Published Time:
2023-03-23
Public Notice Period: March 23, 2023
In order to effectively improve the company's production and operation status, enhance the company's economic benefits, reduce pollutant emissions, and at the same time, in line with the company's development needs, in accordance with the requirements of the "Clean Production Promotion Law of the People's Republic of China", "Clean Production Audit Measures", "Detailed Rules for the Implementation of Clean Production Audit in Henan Province", and "Notice of the Henan Provincial Ecology and Environment Department on the Announcement of the List of Enterprises Implementing Clean Production Audits in Henan Province in 2023" (Yu Huan Ban [2023] No. 11), the company's pre-audit basic information and production and emission status are hereby publicized to the public. All sectors of society are requested to supervise the implementation of clean production audits by our company.
I. Basic Information of the Enterprise
Joincare Pharmaceutical Group Industry Co., Ltd. is a publicly listed joint-stock company. Its predecessor, Shenzhen Tai Tai Pharmaceutical Co., Ltd., is a large-scale modern pharmaceutical enterprise established in 1992. Jiaozuo Healthyuan Bio-products Co., Ltd. is a wholly-owned subsidiary of Joincare Pharmaceutical Group Industry Co., Ltd. invested and constructed in Jiaozuo. It is located south of Jinguang Power Company in Wanfang Industrial Park, Wuwang Office, Macun District, Jiaozuo City, with a total investment of nearly 2.2 billion yuan. The main products and production scale are 2000t 7-ACA, 1000t D-7ACA, 150t mycophenolic acid, 200t demethylchlortetracycline hydrochloride, 200 tons 4AA, etc., annually.
See the table below for basic enterprise information.

See the table below for the use of toxic and harmful raw materials by the enterprise.

II. Pre-audit Sewage Information
1. Wastewater
The company's wastewater mainly includes production wastewater, domestic sewage, and clean drainage. Production wastewater includes cephalosporin C production line wastewater (including bacterial residue drying sewage condensate, adsorption wastewater, high-COD adsorption top washing wastewater, low-COD adsorption top washing wastewater, adsorption regeneration acidic wastewater, decolorization regeneration acidic wastewater), methanol rectification system wastewater, alkali solution recovery wastewater, 7-ACA synthesis production line wastewater (including nanofiltration refined wastewater, refined column regeneration wastewater, washing centrifuge wastewater, ethyl acetate stratified water), waste liquid recovery production line wastewater (including adsorption wastewater, adsorption regeneration acidic wastewater, decolorization regeneration acidic wastewater), D-7ACA synthesis production line wastewater (including nanofiltration refined wastewater, refined column regeneration wastewater, washing centrifuge wastewater, ethyl acetate stratified water), equipment washing water, fermentation exhaust gas treatment system drainage, workshop floor washing water, wastewater treatment plant exhaust gas treatment system drainage, refining workshop nanofiltration concentration dialysis water and 7-ACA workshop nanofiltration concentration dialysis water; the clean drainage generated by the project mainly includes soft water preparation wastewater and cooling circulating water external drainage.
Among them, the nanofiltration concentration dialysis water produced in the refining workshop and the 7-ACA workshop is used comprehensively as recycled water or adsorption top washing water; the adsorption wastewater, high-COD top washing wastewater, and methanol rectification system wastewater W6 produced by cephalosporin C production are high-concentration wastewater, and this part of the wastewater is treated in the anaerobic system of the wastewater treatment plant before being treated together with other wastewater in the main system of the wastewater treatment plant; clean drainage is discharged directly from the general outlet.
The factory area has a wastewater treatment plant, including an anaerobic system and a main wastewater treatment system. The anaerobic system treatment process is adjustment + hydrolysis acidification + UASB, with a design treatment scale of 3500m 3 /d. The main wastewater treatment system includes one CASS treatment device and one A/O treatment device, designed in parallel, to jointly treat wastewater. According to the enterprise 2022 annual detection report and the average value of online wastewater detection, it is known that the detection concentrations of COD, ammonia nitrogen, total nitrogen, pH, total phosphorus, chromaticity, suspended solids, BOD 5 total organic carbon, and total zinc in the enterprise are 98mg/L, 14.35mg/L, 33mg/L, 6.0, 0.053mg/L, 36 times, 56mg/L, 14.8mg/L, 28.55mg/L, 0.004mg/L respectively, meeting the requirements of "Henan Provincial Emission Standard for Water Pollutants from Fermentation Pharmaceutical Industry" (DB41/758-2012) and the wastewater discharge agreement signed with the Xiuwu Branch of Kanda Environmental Water Affairs Company.
According to the company's 2022 report, the annual emissions of COD, ammonia nitrogen, suspended solids, total nitrogen, and total phosphorus are 622.815t, 91.004t, 356.754t, 208.989t, and 0.332t respectively; meeting the discharge permit COD, ammonia nitrogen permitted discharge of 942.1t/a, 105.3t/a.
2. Exhaust Gas



According to the company's 2022 annual detection report and the average value of online exhaust gas detection, the organized and unorganized exhaust gas emissions of the company meet the secondary standards of Table 2 of "Comprehensive Emission Standard for Air Pollutants" (GB16297-1996), the emission limit requirements of the notice on the suggestions for emission in the province-wide special governance of volatile organic compounds in industrial enterprises, and the requirements of Table 2 of "Emission Standard for Malodorous Pollutants" (GB14554-93).
According to the company's 2022 report, the annual emissions of sulfuric acid mist, hydrogen chloride, VOCs, SO 2 particulate matter, and NO X are 1.933t, 0.012t, 0.006t, 24.654t, 0.617t, 1.933t, and 1.319t respectively; meeting the discharge permit VOCs, SO 2 particulate matter, and NO X permitted discharge of 102.5t/a, 0.623t/a, 2.186t/a, 4.47t/a.
3. Solid Waste
(1) General Solid Waste
General industrial solid waste is sludge produced from wastewater treatment. A total of 34416.36 tons were produced in 2022, and entrusted to "Xiuwu County Sunshine Energy-saving Environmental Protection Building Materials Co., Ltd." and "Wuzhi County Donghua Horticultural Field" for disposal as raw materials for sintered bricks or cultivation soil, all of which are compliant.
(2) Hazardous Waste

4. Noise
The main noise sources generated during the company's production process are air compressors, refrigerators, centrifuges, cooling towers, and various pumps. After treatment with noise insulation and vibration reduction measures, they can meet the requirements of Class 3 standards of "Acoustic Environmental Quality Standard" (GB3096-2008).
III. Construction and Operation of Pollution Control Facilities
Pollution control facilities are constructed in accordance with the requirements of provincial and local environmental protection departments and are in normal operation.



IV. Environmental Impact Assessment of Construction Projects and Other Environmental Protection Administrative Licenses
Strictly enforce the "three simultaneous" environmental protection system for construction projects and the environmental impact assessment system for construction projects.
V. Risk Prevention Measures
The company completed the filing of the emergency plan for sudden environmental events on May 17, 2022, with filing number: 410804-2022-001-H.
Jiaozuo Health Yuan Biopharmaceutical Co., Ltd. has already formed certain rules and regulations in environmental management, established an emergency team for sudden environmental events, compiled the "Jiaozuo Health Yuan Biopharmaceutical Co., Ltd. Emergency Plan for Sudden Environmental Events," established a system for environmental risk prevention and control and emergency measures, clarified the responsible institutions for key positions in environmental risk prevention and control, and implemented a regular inspection and maintenance responsibility system. The company's existing comprehensive emergency response capabilities can basically meet the needs of sudden environmental events.